Disease-Causing Mutations in the G Protein Gαs Subvert the Roles of GDP and GTP
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Summary The single most frequent cancer-causing mutation across all heterotrimeric G proteins is R201C in Gαs. The current model explaining the gain-of-function activity of the R201 mutations is through the loss of GTPase activity and resulting inability to switch off to the GDP state. Here, we find that the R201C mutation can bypass the need for GTP binding by directly activating GDP-bound Gαs through stabilization of an intramolecular hydrogen bond network. Having found that a gain-of-function mutation can convert GDP into an activator, we postulated that a reciprocal mutation might disrupt the normal role of GTP. Indeed, we found R228C, a loss-of-function mutation in Gαs that causes pseudohypoparathyroidism type 1a (PHP-Ia), compromised the adenylyl cyclase-activating activity of Gαs bound to a non-hydrolyzable GTP analog. These findings show that disease-causing mutations in Gαs can subvert the canonical roles of GDP and GTP, providing new insights into the regulation mechanism of G proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009 · cited 1×
“Five isoforms of G b and 12 isoforms of G g in mammalian cells have been identified (Khan et al., 2013), among them, the G b 1/G g 2 complex was reported to be one of the combinations that interact with G a s (Rasmussen et al., 2011).”
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Ostrem, J. M., Peters, U., Sos, M. L., Wells, J. A., & Shokat, K. M. (2013) · Nature · doi:10.1038/nature12796 · Cited by 2,557 · cited 1×
“Similar logic has been applied to find small molecule inhibitors of K-Ras (G12C) that bind to the GDP state of the oncogenic mutant in cells (Ostrem et al., 2013), when prior work had suggested oncogenic K-Ras mutants are uniformly in a persistent GTP state.”
Self-citationPhysiological concentrations of purines and pyrimidines
Traut, T. W. (1994) · Molecular and Cellular Biochemistry · doi:10.1007/bf00928361 · Cited by 1,867 · cited 1×
“The R201C mutant was pre-incubated in a low Mg 2+ buffer (1 mM EDTA + 0.1 mM MgCl 2 ) with 400 m M GTP that is close to the physiological concentration of GTP (Traut, 1994); 20 nM [ g - 32 P]GTP was added as an internal standard.”
InfluentialThe Ras-RasGAP Complex: Structural Basis for GTPase Activation and Its Loss in Oncogenic Ras Mutants
Scheffzek, K., Ahmadian, M. R., Kabsch, W., Wiesmüller, L., Lautwein, A., Schmitz, F., & Wittinghofer, A. (1997) · Science · doi:10.1126/science.277.5324.333 · Cited by 1,543 · cited 1×
“Mutations at the G12 position of K-Ras lock K-Ras in its GTP-bound active state through disturbing the ‘‘arginine finger’’ that is provided by GAPs thereby disrupting the transition state for GTP hydrolysis (Bourne, 1997; Rodenhuis et al., 1987; Scheffzek et al., 1997).”
A neo-substrate that amplifies catalytic activity of Parkinson's-disease-related kinase PINK1
Hertz, N. T., Berthet, A., Sos, M. L., Thorn, K. S., Burlingame, A. L., Nakamura, K., & Shokat, K. M. (2013) · Cell · doi:10.1016/j.cell.2013.07.030 · Cited by 275
Self-citation
Research works printed but not linked: 45
- Adams, 2010, PHENIX: a comprehensive Python-based system for macromolecular structure solution, Acta Crystallogr. D Biol. Crystallogr., 66, 213, 10.1107/S0907444909052925 · DOI · Paper page
- Battye, 2011, iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM, Acta Crystallogr. D Biol. Crystallogr., 67, 271, 10.1107/S0907444910048675 · DOI · Paper page
- Biasini, 2014, SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information, Nucleic Acids Res., 42, 10.1093/nar/gku340 · DOI · Paper page
- Bourne, 1997, G proteins. The arginine finger strikes again, Nature, 389, 673, 10.1038/39470 · DOI
- Brandt, 1985, GTPase activity of the stimulatory GTP-binding regulatory protein of adenylate cyclase, Gs. Accumulation and turnover of enzyme-nucleotide intermediates, J. Biol. Chem., 260, 266, 10.1016/S0021-9258(18)89726-5 · DOI
- Brandt, 1986, Catecholamine-stimulated GTPase cycle. Multiple sites of regulation by beta-adrenergic receptor and Mg2+ studied in reconstituted receptor-Gs vesicles, J. Biol. Chem., 261, 1656, 10.1016/S0021-9258(17)35991-4 · DOI · Paper page
- Coleman, 1998, Crystal structures of the G protein Gi alpha 1 complexed with GDP and Mg2+: a crystallographic titration experiment, Biochemistry, 37, 14376, 10.1021/bi9810306 · DOI
- De Haan, 2004, Cholera toxin: a paradigm for multi-functional engagement of cellular mechanisms (Review), Mol. Membr. Biol., 21, 77, 10.1080/09687680410001663267 · DOI · Paper page
- Emsley, 2010, Features and development of Coot, Acta Crystallogr. D Biol. Crystallogr., 66, 486, 10.1107/S0907444910007493 · DOI · Paper page
- Evans, 2006, Scaling and assessment of data quality, Acta Crystallogr. D Biol. Crystallogr., 62, 72, 10.1107/S0907444905036693 · DOI · Paper page
- Flock, 2015, Universal allosteric mechanism for Gα activation by GPCRs, Nature, 524, 173, 10.1038/nature14663 · DOI · Paper page
- Gilman, 1987, G proteins: transducers of receptor-generated signals, Annu. Rev. Biochem., 56, 615, 10.1146/annurev.bi.56.070187.003151 · DOI · Paper page
- Gilman, 1995, G Proteins and regulation of adenylate cyclase (Nobel lecture), Angew. Chem. Int. Ed. Engl., 34, 1406, 10.1002/anie.199514061 · DOI
- Goricanec, 2016, Conformational dynamics of a G-protein α subunit is tightly regulated by nucleotide binding, Proc. Natl. Acad. Sci. USA, 113, E3629, 10.1073/pnas.1604125113 · DOI · Paper page
- Gout, 2014, Interplay of Mg2+, ADP, and ATP in the cytosol and mitochondria: unravelling the role of Mg2+ in cell respiration, Proc. Natl. Acad. Sci. USA, 111, E4560, 10.1073/pnas.1406251111 · DOI · Paper page
- Hanoune, 2001, Regulation and role of adenylyl cyclase isoforms, Annu. Rev. Pharmacol. Toxicol., 41, 145, 10.1146/annurev.pharmtox.41.1.145 · DOI · Paper page
- Higashijima, 1987, The effect of GTP and Mg2+ on the GTPase activity and the fluorescent properties of Go, J. Biol. Chem., 262, 757, 10.1016/S0021-9258(19)75850-5 · DOI · Paper page
- Higashijima, 1987, The effect of activating ligands on the intrinsic fluorescence of guanine nucleotide-binding regulatory proteins, J. Biol. Chem., 262, 752, 10.1016/S0021-9258(19)75849-9 · DOI · Paper page
- Higashijima, 1987, Effects of Mg2+ and the beta gamma-subunit complex on the interactions of guanine nucleotides with G proteins, J. Biol. Chem., 262, 762, 10.1016/S0021-9258(19)75851-7 · DOI · Paper page
- Iiri, 1997, Conditional activation defect of a human Gsalpha mutant, Proc. Natl. Acad. Sci. USA, 94, 5656, 10.1073/pnas.94.11.5656 · doi:10.1073/pnas.94.11.5656
- Kahn, 1984, ADP-ribosylation of Gs promotes the dissociation of its alpha and beta subunits, J. Biol. Chem., 259, 6235, 10.1016/S0021-9258(20)82131-0 · doi:10.1016/s0021-9258(20)82131-0
- Khan, 2013, The expanding roles of Gβγ subunits in G protein-coupled receptor signaling and drug action, Pharmacol. Rev., 65, 545, 10.1124/pr.111.005603 · DOI · Paper page
- Lambright, 1994, Structural determinants for activation of the alpha-subunit of a heterotrimeric G protein, Nature, 369, 621, 10.1038/369621a0 · DOI · Paper page
- Landis, 1989, GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours, Nature, 340, 692, 10.1038/340692a0 · DOI · Paper page
- Le, 2013, Site-specific and regiospecific installation of methylarginine analogues into recombinant histones and insights into effector protein binding, J. Am. Chem. Soc., 135, 2879, 10.1021/ja3108214 · DOI
- Lemos, 2015, GNAS mutations in Pseudohypoparathyroidism type 1a and related disorders, Hum. Mutat., 36, 11, 10.1002/humu.22696 · DOI
- Leyme, 2014, Different biochemical properties explain why two equivalent Gα subunit mutants cause unrelated diseases, J. Biol. Chem., 289, 21818, 10.1074/jbc.M114.549790 · DOI
- McCoy, 2007, Phaser crystallographic software, J. Appl. Cryst., 40, 658, 10.1107/S0021889807021206 · DOI · Paper page
- Mixon, 1995, Tertiary and quaternary structural changes in Gi alpha 1 induced by GTP hydrolysis, Science, 270, 954, 10.1126/science.270.5238.954 · DOI · Paper page
- Muntz, 1992, Influence of gamma subunit prenylation on association of guanine nucleotide-binding regulatory proteins with membranes, Mol. Biol. Cell, 3, 49, 10.1091/mbc.3.1.49 · DOI
- Nishimura, 2010, Structural basis for the specific inhibition of heterotrimeric Gq protein by a small molecule, Proc. Natl. Acad. Sci. USA, 107, 13666, 10.1073/pnas.1003553107 · DOI · Paper page
- O’Hayre, 2013, The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer, Nat. Rev. Cancer, 13, 412, 10.1038/nrc3521 · DOI · Paper page
- Phillips, 1988, The intrinsic fluorescence of the alpha subunit of transducin. Measurement of receptor-dependent guanine nucleotide exchange, J. Biol. Chem., 263, 15498, 10.1016/S0021-9258(19)37616-1 · DOI
- Rodenhuis, 1987, Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung, N. Engl. J. Med., 317, 929, 10.1056/NEJM198710083171504 · DOI · Paper page
- Romani, 2011, Cellular magnesium homeostasis, Arch. Biochem. Biophys., 512, 1, 10.1016/j.abb.2011.05.010 · DOI · Paper page
- Sprang, 2016, Invited review: activation of G proteins by GTP and the mechanism of Gα-catalyzed GTP hydrolysis, Biopolymers, 105, 449, 10.1002/bip.22836 · DOI
- Sunahara, 1997, Interaction of Gsalpha with the cytosolic domains of mammalian adenylyl cyclase, J. Biol. Chem., 272, 22265, 10.1074/jbc.272.35.22265 · DOI · Paper page
- Sunahara, 1997, Crystal structure of the adenylyl cyclase activator Gsalpha, Science, 278, 1943, 10.1126/science.278.5345.1943 · DOI · Paper page
- Tam, 2014, A novel mutation in pseudohypoparathyroidism type 1a in a Chinese woman and her son with hypocalcaemia, Hong Kong Med. J., 20, 258, 10.12809/hkmj134025 · DOI
- Vallar, 1987, Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas, Nature, 330, 566, 10.1038/330566a0 · DOI · Paper page
- Wall, 1995, The structure of the G protein heterotrimer Gi α 1 β 1 γ 2, Cell, 83, 1047, 10.1016/0092-8674(95)90220-1 · DOI · Paper page
- Warner, 1999, A mutation in the heterotrimeric stimulatory guanine nucleotide binding protein alpha-subunit with impaired receptor-mediated activation because of elevated GTPase activity, Proc. Natl. Acad. Sci. USA, 96, 4268, 10.1073/pnas.96.8.4268 · DOI
- Warner, 1998, A novel mutation in the switch 3 region of Gsalpha in a patient with Albright hereditary osteodystrophy impairs GDP binding and receptor activation, J. Biol. Chem., 273, 23976, 10.1074/jbc.273.37.23976 · DOI
- Winn, 2011, Overview of the CCP4 suite and current developments, Acta Crystallogr. D Biol. Crystallogr., 67, 235, 10.1107/S0907444910045749 · DOI · Paper page
- Zuev, 2004, Singlet vinylcarbenes: spectroscopy and photochemistry, J. Am. Chem. Soc., 126, 12220, 10.1021/ja046309q · doi:10.1021/ja046309q
Cited by
Ou, S.-H. I., Jänne, P. A., Leal, T. A., Rybkin, I. I., Sabari, J. K., Barve, M. A., Bazhenova, L., Johnson, M. L., Velastegui, K. L., Cilliers, C., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02752 · Cited by 322
Fonin, A. V., Darling, A. L., Kuznetsova, I. M., Turoverov, K. K., & Uversky, V. N. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03276-1 · Cited by 91
KRAS: Biology, Inhibition, and Mechanisms of Inhibitor Resistance
Ash, L. J., Busia-Bourdain, O., Okpattah, D., Kamel, A., Liberchuk, A., & Wolfe, A. L. (2024) · Current Oncology · doi:10.3390/curroncol31040150 · Cited by 68
“Interestingly, in KRAS wildtype cells, the compound was able to prevent the KRAS–RAF interaction; however, the inhibition of p-ERK and growth were markedly less pronounced compared to cells with mutant KRAS.”
ResultMechanistic insights into G-protein coupling with an agonist-bound G-protein-coupled receptor
Batebi, H., Pérez-Hernández, G., Rahman, S. N., Lan, B., Kamprad, A., Shi, M., Speck, D., Tiemann, J. K. S., Guixà-González, R., Reinhardt, F., et al. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-024-01334-2 · Cited by 38
Metadata
- Authors
- Hu, Q., & Shokat, K. M.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2018-05
- Volume
- 173
- Issue
- 5
- Pages
- 1254-1264.e11
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2796302334
- Cited by
- 65
- References
- 5
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 381 d)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (R01CA190408)
- Samuel Waxman Cancer Research Foundation
- Damon Runyon Cancer Research Foundation (DRG-[2229-15)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Disease-Causing Mutations in the G Protein Gαs Subvert the Roles of GDP and GTP. https://app.cochat.ai/papers/10.1016/j.cell.2018.03.018
- The paper
- Hu, Q., & Shokat, K. M. (2018). Disease-Causing Mutations in the G Protein Gαs Subvert the Roles of GDP and GTP. Cell. https://doi.org/10.1016/j.cell.2018.03.018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.